The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
ZUMA-2: Phase 2 multicenter study evaluating efficacy of kte-C19 in patients with relapsed/refractory mantle cell lymphoma.
 
Michael Wang
Honoraria - Acerta Pharma; Janssen; Pharmacyclics
Consulting or Advisory Role - Acerta Pharma; Adienne; Asana Biosciences; Celgene; IO Biotech; Janssen; MORE Health; Nordic Bioscience
Research Funding - Asana Biosciences; AstraZeneca; BeiGene; Celgene; Janssen; Juno Therapeutics; Kite/Gilead; Novartis; Oncoceutics
Travel, Accommodations, Expenses - Acerta Pharma; Celgene; Janssen; Kite/Gilead; Pharmacyclics
 
Frederick Lundry Locke
Honoraria - Kite/Gilead
Consulting or Advisory Role - Cellular Biomedicine Group
Research Funding - Kite/Gilead
Patents, Royalties, Other Intellectual Property - Sureivin Vaccine Patent (Inst)
 
Javier Munoz
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; Bristol-Myers Squibb; Gilead Sciences; Janssen; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - Kite, a Gilead company
 
Andre Goy
Honoraria - Acerta Pharma; Celgene; Pharmacyclics; Takeda
Consulting or Advisory Role - Acerta Pharma; Celgene; Infinity Pharmaceuticals; Pharmacyclics; Takeda
Speakers' Bureau - Pharmacyclics; Takeda
Research Funding - Clinical Trials Through Institution
 
Houston Eccleston Holmes
Consulting or Advisory Role - Bayer; Janssen; Rigel
Speakers' Bureau - Kite, a Gilead company; Seagen
Research Funding - Juno Therapeutics; Kite/Gilead; Seagen; Unum Therapeutics
Patents, Royalties, Other Intellectual Property - Patent Pending
Travel, Accommodations, Expenses - Bayer; Kite/Gilead
 
Tanya Siddiqi
Consulting or Advisory Role - Juno Therapeutics
Speakers' Bureau - Pharmacyclics/Janssen; Seagen
Research Funding - Acerta Pharma (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Juno Therapeutics; Kite, a Gilead company
 
Ian Flinn
Stock and Other Ownership Interests - RainTree Oncology Services
Research Funding - Acerta Pharma (Inst); Agios (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunogen (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Peter A McSweeney
Honoraria - Kite/Gilead
Consulting or Advisory Role - Kite/Gilead
 
Patrick Michael Reagan
Research Funding - Seagen
 
Brian Thomas Hill
Honoraria - Gilead Sciences; Pharmacyclics
Consulting or Advisory Role - Abbvie/Genentech; Novartis; Seagen
Research Funding - Abbvie (Inst); Karyopharm Therapeutics (Inst)
 
Caron A. Jacobson
Consulting or Advisory Role - Bayer; Kite/Gilead; Pfizer; Pharmacyclics
Speakers' Bureau - Cowen
 
David A. Rizzieri
Consulting or Advisory Role - Kite/Gilead
Travel, Accommodations, Expenses - Kite/Gilead
 
Leonard T. Heffner
Research Funding - Kite/Gilead
Travel, Accommodations, Expenses - Kite/Gilead
 
Samantha Mary Jaglowski
Consulting or Advisory Role - Juno Therapeutics; Kite/Gilead; Novartis
Research Funding - Kite/Gilead; Novartis; Unum Therapeutics
 
David Bernard Miklos
Honoraria - Sanofi; Sanofi
Consulting or Advisory Role - Adaptive Biotechnologies; Kite, a Gilead company; Pharmacyclics/Janssen
Research Funding - Kite, a Gilead company; Novartis; Pharmacyclics; Roche/Genentech
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Kite, a Gilead company; Pharmacyclics/Janssen; Sanofi
 
Paul Shaughnessy
Honoraria - Millennium; Sanofi
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Millennium; Sanofi
Travel, Accommodations, Expenses - Millennium; Sanofi
 
Sherry Unabia
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
John M. Rossi
No Relationships to Disclose
 
Yizhou Jiang
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Rajul K. Jain
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Amgen; Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - Kite, a Gilead company
Travel, Accommodations, Expenses - Kite, a Gilead company